声明
Chapter 1.Introduction
1.1.Fundamental aspects of gene therapy strategy
1.1.1.Limitations associated with gene delivery system
1.1.2. Strategies to introduce therapeutic cargo
1.2.Syntheticvectors for gene delivery
1.2.1.Cationic lipid based delivery system
1.2.2.Polymeric delivery system
1.3.Cell penetrating peptides (CPPs)
1.3.1. Classificationof CPPs
1.3.2. Mechanismof uptake
1.3.3. Applications of CPPs
1.4.RBC vesicles as disguised therapeutic carriers
1.4.1. Pharmacokinetics, biodistribution, and targets ofRBC-loaded drugs
1.4.2. Drug delivery by modified RBC(mRBC)
1.4.3. Characteristics ofRBCs mediated nanoparticles
Chapter2.Experimental analysis
2.1. Introduction
2.2. Materials and methods
2.2.1. Materials
2.2.2. Synthesis of disulfide polyethylenimine(SS-PEI)
2.2.3. Characterization of polymer
2.2.4. Buffer capacity of cationic polymer
2.2.5. Formation of polymer-pDNA complexes with different N/P ratios
2.2.6. Preparation of RBCs vesicles and RBCs-polyplexes
2.2.7. Physiochemical characterization of cationic polymer, polymer-DNA complexes and RBC-polyplexes nanoparticles
2.2.8. Hemolysis assay
2.2.9. Cytocompatibilityof Complex
2.2.9.Macrophage Uptake
Chapter3. Results andDiscussions
3.1. Preparation of disulfide PEI1.8kDa
3.2. Buffer capacity
3.3. Hydrodynamic size and polydispersity index
3.4. Zeta potential or surface charge
3.5. Morphology of RBC vesicles
3.6. Preparation of the NP/pZNF580/RBCs
3.6.Cytocompatibility of Complex
3.7.Macrophage Uptake
Chapter4. Conclusion andfuture perspectives
4.1. Future perspectives
参考文献
Participation in scientific research activities
致谢